Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 2481-2490 of 2760 for cancer

Edit search filters
  1. Spinal Cord Stimulation to Treat Chemotherapy-Induced Peripheral Neuropathy

    Rochester, MN

  2. A Study to Evaluate Yttrium-90 Therapy for Radiation Lobectomy

    Jacksonville, FL, Scottsdale/Phoenix, AZ

  3. Return of Results of Pharmacogenomic Testing for Genes Involved in Metabolism of 5FU and Capecitibine

    Rochester, MN

  4. Quality-Adjusted Survival in Allogeneic Hematopoietic Cell Transplant Patients

    Rochester, MN

  5. Developing Criteria for Treatment of Neurofibromatosis Type 1 Associated Optic Pathway Glioma

    Rochester, MN

  6. A Study to Determine the Effects of COVID-19 in Cancer Patients

    Scottsdale/Phoenix, AZ, Mankato, MN, La Crosse, WI, Eau Claire, WI, Rochester, MN

  7. A Study of the Reliability and Validity of Patient Reported Outcome Measures in Head and Neck Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  8. Epigenomic Biomarkers of HIV-Associated Hepatocellular Cancer in Nigeria

    Rochester, MN

  9. A Study to Assess Multiparametric MR Elastography (MRE) in Diagnosing and Monitoring Cirrhosis or Hepatocellular Carcinoma (HCC) Patients

    Rochester, MN

  10. Patients with Inflammatory Bowel Disease (IBD) are at Increased Risk for Colorectal Cancer and Early Dysplasia

    Rochester, MN

.

Mayo Clinic Footer